Fetal RHD Genotyping in Maternal Plasma at 11–13 Weeks of Gestation
Authors:
- Kirstin FinningKFKirstin Finning
- Ramesh KuppusamyRKRamesh Kuppusamy
- Geoff DanielsGDGeoff Daniels
- Kypros H. NicolaidesKNKypros H. Nicolaides
- 8 January 2011
- journal article
- research article
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 29 (4) , 301-306
Abstract
Objective: To examine the feasibility of fetal RHD genotyping at 11–13 weeks’ gestation from analysis of circulating cell-free fetal DNA (ccffDNA) in the plasma of RhD negative pregnant women using a high-throughput robotic technique. Methods: Stored plasma (0.5 ml) from 591 RhD negative women was used for extraction of ccffDNA by a robotic technique. Real-time quantitative polymerase chain reaction (PCR) with probes for exons 5 and 7 of the RHD gene was then used to determine the fetal RHD genotype, which was compared to the neonatal RhD phenotype. Results: In total there were 502 (85.7%) cases with a conclusive result and 84 (14.3%) with an inconclusive result. The prenatal test predicted that the fetus was RhD positive in 332 cases and in all of these the prediction was correct, giving a positive predictive value of 100% (95% CI 96.8–100). The test predicted that the fetus was RhD negative in 170 cases and in 164 of these the prediction was correct, giving a negative predictive value for RhD positive fetuses of 96.5% (95% CI 93.7–99.2). Conclusion: The findings demonstrate the feasibility and accuracy of non-invasive fetal RHD genotyping at 11–13 weeks with a high-throughput technique.Keywords
This publication has 26 references indexed in Scilit:
- Non-invasive fetal RHD genotyping tests: A systematic review of the quality of reporting of diagnostic accuracy in published studiesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2009
- Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008Transfusion Medicine and Hemotherapy, 2009
- Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospectsPrenatal Diagnosis, 2008
- Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility studyBMJ, 2008
- Polymerase-Chain-Reaction-Based Detection of Fetal Rhesus D and Y-Chromosome-Specific DNA in the Whole Blood of Pregnant Women during Different Trimesters of PregnancyMedical Principles and Practice, 2007
- Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood—A meta-analysisAmerican Journal of Obstetrics and Gynecology, 2006
- Use of Bi‐Allelic Insertion/Deletion Polymorphisms as a Positive Control for Fetal Genotyping in Maternal BloodAnnals of the New York Academy of Sciences, 2006
- Prenatal genotyping ofRHDandSRYusing maternal bloodVox Sanguinis, 2003
- Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal DiagnosisThe American Journal of Human Genetics, 1998
- Feto‐maternal haemorrhage associated with genetic amniocentesis: results of a randomized trialBJOG: An International Journal of Obstetrics & Gynaecology, 1987